The Spanish Agency for Medicines and Health Products (AEMPS) has introduced an accelerated evaluation process (fast-track) to enhance Spain’s appeal for research on innovative medicines. This process will reduce the timelines for studies meeting the following criteria: Interested…
The Clinical Trials Information System (CTIS) is the online system for the regulatory submission, authorization, and supervision of clinical trials in the European Union and the European Economic Area. CTIS is the single entry point for clinical trials in…
According to Farmaindustria, Spain is the European country with the highest participation in clinical trials. Of the 1,944 clinical trials authorized in the European Union through the new European Information System (CTIS), Spanish sites participated in 845 (43%).…
This month, we want to share the acknowledgment that APICES has received in the recent publication of an international clinical trial, titled “Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase…
This month, we want to share the acknowledgment that APICES has received in the recent publication titled “A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the Geminis study”
Amelia Martín Uranga, Associate Director of Clinical and Translational Research at Farmaindustria, explains why Spain is an international leader in clinical trials. Spain is the second country in terms of investment by the pharmaceutical industry, behind the United…
Acknowledgement for APICES collaboration in study ABIDO published in ” European Journal of Cancer” This month, we want to share the acknowledgment that APICES has received in the recent publication titled “A phase II randomised trial of abiraterone…
Acknowledgement for APICES collaboration in DERMIA study published in “Supportive Care in Cancer” This month, we want to share the acknowledgment that APICES has received in the recent publication titled “A phase 2 study for evaluating doxycycline 50…
Acknowledgement for APICES collaboration in ABACUS trial published in “European Urology” Once more time we are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients…
Acknowledgement for APICES collaboration in DART 01/05 study published in “The Lancet Oncology” Once more time we are privileged to share the acknowledgment that APICES has received in the recent publication titled: “High-dose radiotherapy and risk-adapted androgen deprivation…
